Small Molecules

11 Apr 2007 Coley Pharmaceutical Group Announces Completion of Patient Enrollment in Pfizer's Two Pivotal Phase III NSCLC Clinical Trials
11 Apr 2007 Pfizer and Renovis Extend Research Collaboration to Identify Small Molecule VR1 Antagonists
11 Apr 2007 NeuroSearch's license partner Astellas initiates clinical Phase Ib study with ACR16 in patients with schizophrenia
11 Apr 2007 Novalar Submits New Drug Application for Anesthetic Reversal Agent NV-101
11 Apr 2007 Studies Intended to Broaden Market Potential for Neuropathic Pain Uses
11 Apr 2007 Ambit Biosciences Begins Dosing Patients in Phase I Clinical Trial of Lead Kinase Inhibitor AC220
11 Apr 2007 CoMentis Initiates Phase II Clinical Trial for AMD Eye Drop Therapy
11 Apr 2007 Array BioPharma Advances p38 Inhibitor, ARRY-797, into Phase 1 Cancer Patient Trial
10 Apr 2007 GSK and Adolor Announce Preliminary Results from Phase 3 Safety Study of Alvimopan (ENTEREG/ENTRAREG(R))
10 Apr 2007 Threshold Pharmaceuticals Initiates Phase 2 Clinical Trial Evaluating Glufosfamide in Patients With Soft Tissue Sarcoma
10 Apr 2007 Immtech Initiates Phase IIb Clinical Trial to Develop Malaria Prevention and Treatment Therapies
07 Apr 2007 Wyeth Provides Update on FDA Review of the Torisel New Drug Application
07 Apr 2007 Abbott Announces FDA Approval of a New Coated Niaspan Tablet
06 Apr 2007 Memory Pharmaceuticals Completes Enrollment in Phase 2a MEM 1003 Alzheimer's Disease Trial
06 Apr 2007 ARIAD Provides Update Regarding AP23573 Phase 3 Trial in Metastatic Sarcoma
06 Apr 2007 Cleveland BioLabs Phase II Hormone-Refractory Prostate Cancer Trial Advances to Next Phase
05 Apr 2007 Metabasis Therapeutics Initiates a Proof of Concept Study for MB07803, Its Second Product Candidate for the Treatment of Type 2 Diabetes
05 Apr 2007 Alizyme Announces a Product & Company Update
05 Apr 2007 Pharmacyclics' Xcytrin New Drug Application for Treatment of Lung Cancer Brain Metastases to Be Filed Over Protest
05 Apr 2007 ECOG Phase III Newly Diagnosed Multiple Myeloma Trial (E4A03) Reports LENALIDOMIDE Plus Low-Dose Dexamethasone Suggests Survival Advantage for Patients with Multiple Myeloma
05 Apr 2007 Merrimack Pharmaceuticals Initiates Enrollment in a Phase 2 Pilot Study of
05 Apr 2007 Meditrina Pharmaceuticals, Inc. Initiates phase II Trial and raises $4.4M in initial funding.
05 Apr 2007 Portola Pharmaceuticals Announces Positive Phase II Results for PRT054021 for Prevention of Venous Thromboembolism Following Total Knee Replacement Surgery
05 Apr 2007 Innocoll Receives FDA Approval to Commence Phase 2 Clinical Development with its CollaRx(R) BUPIVACAINE IMPLANT for the Management of Post-operative Pain
05 Apr 2007 Novagali Pharma Announces Positive Vekacia(R) Clinical Results from Pivotal Phase III Trial in Vernal Keratoconjunctivitis

La Merie Biologics

FREE Weekly News Bulletin

Sign Up

2018 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Sign Up